| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/29/2008 | US20080124322 Activation and inhibition of the immune system |
| 05/29/2008 | US20080124313 Nucleotide sequences coding methionyl tRNA synthetase protein for use in identifying modulators for prevention and treatment of bacterial infection |
| 05/29/2008 | US20080124308 Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins |
| 05/29/2008 | US20080124286 for enhancing epidermal and/or hair follicle stem cell production, cell renewal, and/or growth of the skin, hair and nails, by topical administration; cyanobacteria and green algae |
| 05/29/2008 | CA2671437A1 Targeted delivery of therapeutic agents with lyophilized matrices |
| 05/29/2008 | CA2667705A1 Suppression of mitochondrial oxidative stress |
| 05/28/2008 | EP1925677A2 Marker genes for determining renal toxicity |
| 05/28/2008 | EP1925662A1 Recombinant Poxvirus-Cytomegalovirus Compositions and uses |
| 05/28/2008 | EP1925626A1 Novel multifunctional cytokines |
| 05/28/2008 | EP1924294A2 Compositions and their uses directed to ptpru |
| 05/28/2008 | EP1924293A1 Composition and method for prevention and treatment of type i diabetes |
| 05/28/2008 | EP1723417A4 C20orf23 as modifier of the igfr pathway and methods of use |
| 05/28/2008 | EP1723415A4 Pdes as modifiers of the igfr pathway and methods of use |
| 05/28/2008 | EP1537243B1 Method of diagnosing ovarian endometriosis |
| 05/28/2008 | EP1370684B1 Polynucleotides related to colon cancer |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1307582B1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/28/2008 | EP1196587B1 Antigenic meningococcal peptides |
| 05/28/2008 | EP1157105B1 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 05/28/2008 | EP1090127B1 Adh7 nucleotides |
| 05/28/2008 | EP0968295B1 Vectors having enhanced expression and methods of making and uses thereof |
| 05/28/2008 | EP0953647B1 Method for preparing retrovirus vector for gene therapy |
| 05/28/2008 | EP0811069B1 Chimeric adenoviral fiber protein and methods of using same |
| 05/28/2008 | CN101189343A Multiple RNA polymerase III promoter expression constructs |
| 05/28/2008 | CN101188940A Compositions and methods for the therapeutic treatment of diabetes |
| 05/28/2008 | CN101187663A Suppressor genes |
| 05/28/2008 | CN101186928A Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 05/28/2008 | CN101186925A General-purpose highly effective eukaryon expression carrier p3I-GFPN and mastitis-resisting transgene carrier constructed by the same |
| 05/28/2008 | CN101186637A Method for inhibiting influenza virus infection and medicament thereof |
| 05/28/2008 | CN101185763A Use of duplicating type recombinant adenovirus |
| 05/28/2008 | CN100390292C Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/28/2008 | CN100390291C Conditionally replicating viral vectors and their use |
| 05/28/2008 | CN100390290C Method for gene introduction into target cells by retrovirus |
| 05/28/2008 | CN100390286C Novel enzyme gene and its expression product |
| 05/28/2008 | CN100390195C Modulators of function of FAS receptors and other proteins |
| 05/28/2008 | CN100389831C Gene engineering vaccine used for preventing pig cysticercosis and its preparation method |
| 05/27/2008 | US7378515 Synthetic gagpol genes and their uses |
| 05/27/2008 | US7378509 Bind p50/p65 and/or cRel/p50 heterodimers over p50/p50 homodimers; for inflammatory, immune or autoimmune disease, cancer |
| 05/27/2008 | US7378496 kits for prognosis and treatment regimen of a subject having or at risk for neuropsychiatric, neurological, neuromuscular, and immunological disorder |
| 05/27/2008 | US7378494 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide |
| 05/27/2008 | US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder |
| 05/27/2008 | US7378273 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering |
| 05/27/2008 | US7378272 Mosquito cell culture for propagation of sindbis viral vectors; genetic engineering and vehicles for gene transfer |
| 05/27/2008 | US7378265 Such as adenoviruses with tri-n-butyl phosphate solvent; replication-defective |
| 05/27/2008 | US7378096 biodrugs comprising heat shock protein or glucose-regulated proteins complexed with immuogens including glycoproteins, her2/neu proteins or tuberculosis antigens, and carriers, used as anticarcinogenic agents |
| 05/27/2008 | US7378092 Immunogenic compositions for induction of anti-tumor immunity |
| 05/27/2008 | US7378089 Supplying suppressive genetic engineered cells; antiinflammatory agents |
| 05/27/2008 | US7378087 Method of enhancing an immune response |
| 05/27/2008 | US7378077 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/27/2008 | CA2145641C Pseudo-adenovirus vectors |
| 05/22/2008 | WO2008061261A2 Preparation and use of cell-synthesized threads |
| 05/22/2008 | WO2008061091A2 Antisense guanidinium peptide nucleic acid (gpna) oligonucleotides as antitumor agents |
| 05/22/2008 | WO2008060776A2 Atap peptides, nucleic acids encoding the same and associated methods of use |
| 05/22/2008 | WO2008060695A2 Antiviral inhibition of casein kinase ii |
| 05/22/2008 | WO2008060557A2 Efficient nuclear delivery of antisense oligonucleotides |
| 05/22/2008 | WO2008060485A2 Diagnosing, monitoring and treating inflammation |
| 05/22/2008 | WO2008060478A2 Hedgehog signaling pathway proteins and uses thereof |
| 05/22/2008 | WO2008060385A2 Li-key enhanced vaccine potency |
| 05/22/2008 | WO2008060362A2 Methods and compositions for the treatment of skin diseases and disorders |
| 05/22/2008 | WO2008060356A2 Methods and compositions for gene therapy |
| 05/22/2008 | WO2008058451A2 Ultrasound microbubble mediated genes delivery system |
| 05/22/2008 | US20080120734 Compositions and methods for regulated protein expression in gut |
| 05/22/2008 | US20080119433 administering an isolated polynucleotide encoding a nucleic acid or a polypeptide in the skin cells; improve skin thickness, wrinkle, tones, eleasticity, texture, coloring and aging resistance |
| 05/22/2008 | US20080119432 Inhibition Of Metallo-Beta-Lactamase By Rna |
| 05/22/2008 | US20080119431 cyclic oligosaccharides has amine function groups attached through C6 position, for DNA transfer, cell permeation and improve drug intracellular delivery; biocompatibility and low toxicity; cyclodextrins connected through chains of alkylguanidines, tertiary nitrogen |
| 05/22/2008 | US20080119427 Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation |
| 05/22/2008 | US20080119426 modified oligonucleotides is used to treating muscle wasting conditions and promoting muscle growth; farm and food animals; complementary to a myostatin gene; food dietary supplement |
| 05/22/2008 | US20080119425 administering biodrug oligonucleotide anticarcinogenic agents for treating breast cancer, prostate cancer, bladder cancer, ovarian cancer, lung cancer, renal cancer, melanoma, and pancreatic cancer; gene expression inhibition |
| 05/22/2008 | US20080119424 biodrugs contains siRNA or vector encoding siRNA, including a retinoid as antitumor agents, anticarcinogenic agents |
| 05/22/2008 | US20080119423 isolated antisense oligonucleotide hybrids for treating pain in a mammal; biodrugs |
| 05/22/2008 | US20080119412 Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins |
| 05/22/2008 | US20080119404 angiopoietin-related growth factor used as antiobesity agent, an antidiabetic agent, and/or a hypolipidemic agent; polypeptides |
| 05/22/2008 | US20080119387 Contacting small molecule or polypeptide with a cell, cell extract, or purified cell components containing L41 and ribosomes, detecting whether the test composition inhibits the interaction of L41 with the ribosomes; anddetermining whether the test composition inhibits peptidyl transferase activity |
| 05/22/2008 | US20080118956 Viral Particles Containing An Alphavirus-Derived Vector And Method For Preparing Said Viral Particle |
| 05/22/2008 | US20080118553 Tannate salt form of polypeptide mixtures, their preparation and use |
| 05/22/2008 | US20080118535 Surface protein of Neisseria bacteria |
| 05/22/2008 | US20080118526 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/22/2008 | US20080118513 Treatment of immune disorders with antibodies to costimulating polypeptide of T cells |
| 05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
| 05/22/2008 | US20080118510 Vegf-related protein |
| 05/22/2008 | US20080118481 Mononuclear phagocytes in therapeutic drug delivery |
| 05/22/2008 | US20080118480 Methods and Compositions for Directing Migration of Neural Progenitor Cells |
| 05/22/2008 | US20080118471 Constitutive gene expression in conjunction with ionizing radiation |
| 05/22/2008 | US20080118470 Recombinant viral vector comprising adenoviral backbone and coding colony stimulating factor for selective killing of neoplastic cells |
| 05/22/2008 | US20080118469 Anti-angiogenic methods and compositions |
| 05/22/2008 | US20080118466 Treatment of rheumatoid arthritis with soluble fas-ligand cross-linkers |
| 05/22/2008 | US20080118460 Of two biodegradable polymers, one being a homo- or copolylactone having glyceric acid as a monomer, thus having a higher density of functional groups for better small molecule drug conjugation; polymerization, drug conjugation, and purification |
| 05/22/2008 | US20080118437 Therapy for bone metastasis; antibody, antisense or siRNA inhibits expression of MCP-1; docetaxel chemotherapy agent; measure level of expression of MCP-1 relative to non-cancerous prostate tissue; determine treatment course |
| 05/22/2008 | CA2669673A1 Efficient nuclear delivery of antisense oligonucleotides or sirna in vitro and vivo by nano-tranforming polymersomes |
| 05/22/2008 | CA2669669A1 Intra-vascular kidney gene therapy with plasmid encoding bmp-7 |
| 05/22/2008 | CA2667414A1 Methods and compositions for modification of the human glucocorticoid receptor locus |
| 05/22/2008 | CA2663854A1 Methods and compositions for gene therapy |
| 05/21/2008 | EP1923467A2 Adenovirus vectors for gene therapy |
| 05/21/2008 | EP1923466A2 Vectors encoding recombinant AAV genomes |
| 05/21/2008 | EP1923465A1 Inhibitor protein for the WNT signal pathway |
| 05/21/2008 | EP1923072A1 Prophylactic/therapeutic agent for cancer |
| 05/21/2008 | EP1922083A2 Truncated memapsin 2 for use for treating alzheimer's disease |
| 05/21/2008 | EP1319069B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1242111B1 An animal model for studying hormone signalling and method of modulating the signalling |